We collected information about Pliant Therapeutics Inc Hours for you. Follow the liks to find out everything about Pliant Therapeutics Inc Hours.
Pliant’s broad pipeline includes two clinical stage programs, including the first clinical stage, oral, selective small molecule integrin inhibitor. Learn More → Our Patients . Pliant's approach has the potential to significantly advance the treatment of fibrosis. We …
https://www.barrons.com/market-data/stocks/plrx
Complete Pliant Therapeutics Inc. stock information by Barron's. View real-time PLRX stock price and news, along with industry-best analysis. …
https://www.marketwatch.com/investing/stock/plrx/company-profile
Pliant Therapeutics Inc. 260 Littlefield Avenue. South San Francisco, California 94080. Phone 1 650 481-6770. Industry Biotechnology. Sector Health Care/Life Sciences. Fiscal Year-end 12/2021 ...
https://www.marketwatch.com/investing/Stock/PLRX
PLRX | Complete Pliant Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
https://www.nasdaq.com/articles/pliant-therapeutics-inc.-plrx-reports-q3-loss-misses-revenue-estimates
Pliant Therapeutics, Inc. (PLRX) came out with a quarterly loss of $0.75 per share versus the Zacks Consensus Estimate of a loss of $0.71. This compares to loss of $0.47 per share a year ago.
https://www.nasdaq.com/articles/pliant-therapeutics-inc.-plrx-forms-hammer-chart-pattern%3A-time-for-bottom-fishing
The price trend for Pliant Therapeutics, Inc. (PLRX) has been bearish lately and the stock has lost 5.7% over the past four weeks. However, the formation of a hammer chart pattern in its last ...
https://www.barrons.com/market-data/stocks/plrx/research-ratings
Pliant Therapeutics Inc. research and ratings by Barron's. View PLRX revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. ... After …
https://pliantrx.com/careers/
At Pliant Therapeutics, we’re driven to transform the lives of patients by developing best-in-class treatments for fibrotic diseases. Our success depends on the excellence of our people. With this in mind, we are highly vested in the recruitment, training and development of our employees.
https://ir.pliantrx.com/news-releases/news-release-details/pliant-therapeutics-reports-positive-interim-results-phase-2a
Patients undergo a PET scan prior to dosing and at four hours post-dose to evaluate target ... About Pliant Therapeutics, Inc. Pliant is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrotic and related diseases. Pliant's lead product candidate, PLN-74809, is an oral small ...
https://finance.yahoo.com/quote/PLRX/news/
Pliant Therapeutics Inc (NASDAQ: PLRX) stock is moving higher during the premarket session in reaction to interim results from a Phase 2a positron emission tomography (PET) imaging-based trial of ...
Searching for Pliant Therapeutics Inc Hours?
You can just click the links above. The info is collected for you.
